ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Philly Jury Awards $120 Million in Transvaginal Mesh Lawsuit


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Judge's gavel and stethoscope on court room table.

A Philadelphia jury ordered Johnson & Johnson’s Ethicon unit to pay $120 million to Susan McFarland, a 68-year-old woman who said the company’s transvaginal mesh implant caused her pain, inability to have sex and chronic urinary tract infections, The Philadelphia Inquirer reported.

The verdict includes $100 million in punitive damages intended to punish the company for especially harmful behavior.

“I’m so happy for Susan McFarland,” Tammy Jackson, a patient advocate and mesh survivor for over 12 years, told Drugwatch. “I believe the jury saw the truth about mesh. I hope other jurors do the same.”

McFarland received her TVT-O mesh implant in 2008. Most pelvic mesh implants are made of a plastic called polypropylene. They repair pelvic organ prolapse and treat stress urinary incontinence by providing support to weakened tissue.

“I believe the jury saw the truth about mesh. I hope other jurors do the same.”

Tammy Jackson, patient advocate and mesh survivor

According to McFarland’s lawsuit, the mesh eroded tissue in her pelvis and punctured her vagina. She had revision surgery to remove the mesh but continued to suffer complications.

This verdict is the largest pelvic mesh jury verdict against the company, Ethicon spokeswoman Mindy Tinsley told Bloomberg. She said the company would appeal.

Other manufacturers also face mesh lawsuits, but Ethicon has the most federal lawsuits pending against it with 10,415 cases. At one time, that number was 40,719, according to the U.S. Judicial Panel on Multidistrict Litigation.

On April 16, 2019, the FDA stopped all sales of pelvic mesh for prolapse because the agency could not “assure women that these devices were safe and effective long term,” Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, said in the agency’s press release.

Injured by complications related to Transvaginal Mesh? Get a Free Case Review

J&J to Pay $9.9 Million for Failing to Disclose Mesh Risks

In addition to individual mesh lawsuits, Johnson & Johnson also faces lawsuits from states that say the health care giant failed to disclose mesh risks.

Two days before Philadelphia jurors handed up the McFarland verdict, Johnson & Johnson had agreed to pay Washington state $9.9 million to avoid going to trial for “misrepresentations and failure to include serious risks in the instructions and marketing materials for surgical mesh devices,” according to the Washington State Office of the Attorney General.

Attorney General Bob Ferguson sued Johnson & Johnson in May 2016 on grounds that the company violated Washington’s Consumer Protection Act by failing to disclose mesh risks in materials for patients and doctors. According to Ferguson’s office, about 14,000 women in the state have had mesh implanted.

Johnson & Johnson Global Head of Medical Affairs Piet Hinoul said during a deposition that the company knew about the serious risks “from day 1” but did not inform patients of the risks.

Related News

Meanwhile, Tammy Jackson and fellow mesh sufferers in Kentucky helped Attorney General Andy Beshear file a similar lawsuit against Johnson & Johnson in 2016. California Attorney General Kamala D. Harris has also filed a lawsuit.

“Washington state’s attorney general did an amazing job getting $10 million for the ladies of Washington state. I hope more attorneys general do the same,” Jackson said. “I believe the truth about polypropylene mesh is coming to light.”

Ferguson has announced that the money from the settlement will go to help Washington women affected by mesh. Women can fill out a contact form on the state’s website for more information.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine
Edited By
Emily Miller
Emily Miller Managing Editor

4 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Bloomberg Law. (2019, April 25). J&J Unit Ethicon to Appeal $120 Million Pelvic Mesh Verdict. Retrieved from
  2. U.S. Food and Drug Administration. (2019, April 16). FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices. Retrieved from
  3. Washington State Office of the Attorney General. Johnson & Johnson Will Pay $9.9 Million for Failing To Disclose The Risk Of Its Surgical Mesh Devices. Retrieved from
  4. Wood, S. (2019, April 25). Pennsylvania woman awarded $120 million in vaginal mesh case against Johnson & Johnson. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(877) 312-3413